Pacific Radiation Oncology, LLC v. The Queen's Medical Center. , 138 Haw. 14 ( 2016 )


Menu:
  • ***      FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER     ***
    Electronically Filed
    Supreme Court
    SCCQ-15-0000300
    13-JUN-2016
    08:04 AM
    IN THE SUPREME COURT OF THE STATE OF HAWAII
    ---oOo---
    ________________________________________________________________
    PACIFIC RADIATION ONCOLOGY, LLC, a Hawaii Limited Liability
    Corporation, et al., Plaintiffs-Appellants,
    vs.
    THE QUEEN’S MEDICAL CENTER, a Hawaii Non-Profit Corporation,
    et al., Defendants-Appellees.
    ________________________________________________________________
    SCCQ-15-0000300
    CERTIFIED QUESTION FROM THE UNITED STATES DISTRICT COURT
    FOR THE DISTRICT OF HAWAII
    (CIVIL NO. 12-00064 LEK-KSC)
    JUNE 13, 2016
    RECKTENWALD, C.J., NAKAYAMA, McKENNA, POLLACK, AND WILSON, JJ.,
    WITH RECKTENWALD, C.J., CONCURRING SEPARATELY
    OPINION OF THE COURT BY McKENNA, J.
    I.     Introduction
    This court has been asked to provide guidance to the United
    States District Court for the District of Hawaii (“District
    Court”) on questions of Hawaii law.          At issue is whether the
    parties may use, or be compelled to produce, the confidential
    medical records of over 100 cancer patients, in an effort to
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER    ***
    prosecute or defend against claims that the Plaintiff doctors
    steered these patients away from treatment at Defendant Queens
    Medical Center.        The patients are not parties to the underlying
    lawsuit, although 19 of them have been granted intervenor
    status.       All of them have intervened solely to assert their
    right to privacy and seek a prohibition on the use and
    production of their medical records.
    The District Court1 certified the following questions to
    this court:
    1. May a third party who is in lawful possession of a
    patient’s confidential medical records use, or be compelled
    to produce, these records in litigation where the patient
    is not a party?
    2. If a third party may use and/or produce a patient’s
    confidential medical records in litigation, is a de-
    identification process sufficient to protect the patient’s
    privacy interests where the third party already allowed its
    agents access to the patient’s records and its agents
    inadvertently made part of the patient’s medical
    information public?
    This court may “reformulate the relevant state law questions as
    it perceives them to be, in light of the contentions of the
    parties.”       Allstate Ins. Co. v. Alamo Rent-A-Car, Inc., 
    137 F.3d 634
    , 637 (9th Cir. 1998) (citations and quotation marks
    omitted).       To avoid confusion, we reformulate the certified
    questions to clarify that the term “party” refers to the parties
    to the litigation, not to the parties to the physician-patient
    relationship.        We believe that the “parties” in this case are
    the plaintiffs and defendants, and the “third parties” in this
    1
    The Honorable Leslie E. Kobayashi, United States District Judge,
    presided.
    2
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER   ***
    case are the patient intervenors.            We also reformulate the
    question so that a negative answer to the first certified
    question will not preclude us from answering the second
    certified question to the extent we can.             Therefore, the
    reformulated certified questions are:
    1. May a party who is in lawful possession of a patient’s
    confidential medical records use, or be compelled to
    produce, these records in litigation where the patient is
    not a party?
    2. Is a de-identification process sufficient to protect
    the patient’s privacy interests where the party already
    allowed its agents access to the patient’s records and its
    agents inadvertently made part of the patient’s medical
    information public?2
    Hawaii Rules of Appellate Procedure (“HRAP”) Rule 13 (2000)
    governs certified questions.           It provides, in relevant part,
    “When a federal district . . . court certifies to the Hawaii
    Supreme Court that there is involved in any proceeding before it
    a question concerning the law of Hawaii that is determinative of
    the cause and that there is no clear controlling precedent in
    the Hawaii judicial decisions, the Hawaii Supreme Court may
    answer the certified question by written opinion.”               We therefore
    confine our answer to the “law of Hawaii that is determinative
    2
    Defendant urges us to reformulate the certified questions to include
    the following “threshold question”: “Does [Hawaii Revised Statutes (“HRS”) §
    431:10C-]308.7(c) apply to all self-referral involving insured services
    covered by H.R.S. Chapter 431 or only to those involving no-fault auto-
    related services?” We decline to do so. We note that the District Court has
    already concluded that that statute does not apply to health care provider
    referrals and is “limited to the context of motor vehicle insurance” in an
    Order Granting in Part and Denying in Part Plaintiffs’ Motion for Summary
    Judgment on the Counterclaim. The present certified question is not the
    proper vehicle through which Defendant may challenge that order.
    3
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER   ***
    of the cause,” namely article I, section 6 of the Hawaii
    Constitution.    That constitutional provision states, in relevant
    part, “The right of the people to privacy is recognized and
    shall not be infringed without the showing of a compelling state
    interest.”
    We answer the first certified question in the negative.
    Article I, section 6 of the Hawaii Constitution protects the
    health information of patient intervenors to this case.
    Pursuant to that provision, and under the facts of this case,
    the parties cannot use, or be compelled to produce, confidential
    patient medical records in litigation where the patient is not a
    party, absent a compelling state interest.
    As to the second certified question, we do not address
    whether sufficient de-identification is possible where one party
    already allowed its agents access to the patient’s records and
    its agents inadvertently made part of the patient’s medical
    information public.      The de-identification process and
    requirements are set forth under the Health Insurance
    Portability and Accountability Act of 1996 (“HIPAA”), Pub L. No.
    104-191, 110 Stat. 1936 (1996), and its corresponding
    regulations; therefore, the sufficiency of de-identification
    does not “concern[] the law of Hawaii that is determinative of
    the cause.”    HRAP Rule 13.     Whether the use and production of
    4
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER   ***
    de-identified medical records is “sufficient to protect the
    patient’s privacy interests,” however, is a question this court
    can address under article I, section 6.             We hold that the use
    and production of de-identified medical information of patients
    who are not parties to the litigation violates those patients’
    right to privacy under article I, section 6 of the Hawaii
    constitution, as no compelling state interest has been shown in
    this case.
    II.       Background
    The Plaintiffs in this case are Pacific Radiation Oncology,
    LLC; PRO Associates, LLC; John Lederer, M.D.; Vincent Brown,
    M.D.; Paul DeMare, M.D.; Thanh Huynh, M.D.; Laeton Pang, M.D.;
    and Eva Bieniek, M.D. (collectively, “PRO”).              The Plaintiffs
    filed an Amended Complaint for Declaratory and Injunctive Relief
    and for Damages (“Amended Complaint”) against Defendants Queens
    Medical Center and Queens Development Corporation (collectively
    “QMC”).3      The Amended Complaint alleged that the Plaintiffs “had
    a long-standing, 40-year relationship with QMC to provide
    professional radiation oncology therapy services to PRO patients
    at facilities owned by QMC, using equipment, technician support,
    and other services provided by QMC.”            QMC is the only Nuclear
    Regulatory Commission-approved hospital at which radiation
    3
    The Plaintiffs also named as defendants the individual members of the
    Queens Medical Center Board of Trustees. The parties later stipulated to
    dismiss, without prejudice, these individuals.
    5
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER   ***
    oncologists can operate on patients.         Plaintiffs also
    acknowledged that they had “a one-third interest in The Cancer
    Centers of Hawaii [‘TCCH’],” a competitor of QMC.
    According to the Amended Complaint, QMC notified Plaintiffs
    that the QMC Board had decided to convert QMC to a “closed
    radiation therapy department,” meaning that only physicians
    employed by QMC could exercise clinical privileges to provide
    professional radiation oncology services at QMC.            QMC explained
    that it arrived at its decision to terminate PRO’s privileges
    after determining that PRO had “transferr[ed] patients to other
    facilities for no medical reason or patient request. . . .”
    Plaintiffs alleged in their Amended Complaint that QMC’s action
    was intended to destroy their ability to treat patients at
    facilities competing with QMC.
    Plaintiffs’ Amended Complaint raised ten claims for relief:
    a claim of denial of procedural and substantive due process; a
    claim of violation of QMC bylaws and governing regulations;
    three separate claims of intentional and tortious interference;
    four separate claims of unfair, deceptive, anti-competitive and
    illegal trade practices in violation of HRS Chapter 480; and a
    claim of breach of fiduciary duty and bad faith owed to a
    partner.
    QMC filed an Answer and Counterclaim.        Relevant to this
    certified question, QMC counterclaimed that           Plaintiffs Lederer,
    6
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER   ***
    Brown, DeMare, Huynh, and Pang “consulted with and/or began
    treatment of patients referred to them at QMC and then induced
    the patients to receive treatment at TCCH without making timely
    written disclosure of their ownership interests in TCCH,” which
    constituted unfair competition in violation of HRS § 480-2.
    During the course of the litigation, QMC’s law firm
    publicly filed a list naming 132 patients PRO was alleged to
    have diverted to TCCH; also included were the patients’ QMC
    identification numbers and the PRO doctors who consulted and
    treated each patient.      The list was attached as an exhibit to
    (1) a subpoena to TCCH’s custodian of records and (2) a
    discovery request to PRO.       The filing was subsequently sealed.
    Plaintiffs then moved for a temporary restraining order or
    preliminary injunction to prevent further violations of patient
    privacy.    In their moving papers, they alleged that QMC had
    accessed the electronic medical records of 133 cancer patients,
    without consent, to determine if Plaintiffs were directing
    patients to TCCH, and, if so, how much revenue QMC lost as a
    result.    Plaintiffs argued that cancer patient medical records
    would likely include “history and physicals” information
    regarding “the most confidential and sensitive inquiries,
    including prior pregnancies, abortions, sexual activities,
    potency, drug use, psychological issues, depression, AIDS info,
    family history, prior diseases, substance dependency, etc.,
    7
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER   ***
    etc.”       QMC’s alleged breach of patient privacy culminated in the
    disclosure of 132 of the patients’ names in the exhibits to the
    subpoena and discovery request.              Plaintiffs sought to enjoin
    “QMC, its attorneys, and its consultants from reviewing and more
    importantly from publishing the highly confidential information
    including the names of these many, many cancer patients.”
    The District Court granted in part, and denied in part, the
    Plaintiffs’ motion.         Construing the Plaintiffs’ pleading as a
    discovery motion, the District Court granted it, in part, and
    sanctioned defense counsel for publicly filing the list naming
    the 132 cancer patients, in willful violation of the parties’
    Amended Stipulated Protective Order.              The District Court denied
    the motion for a TRO and/or preliminary injunction, in part,
    because the Plaintiffs’ Amended Complaint alleged no claims of
    improper review and use of confidential patient information.4                As
    to whether the Plaintiffs could prevent Defendants from
    obtaining or using confidential patient information, the
    District Court concluded that “the parties must address these
    issues through the normal discovery process.”
    The Magistrate Judge, in turn, issued his Order Regarding
    Discovery Issues.        He found the 132 cancer patients’
    confidential medical records to be relevant to the parties’
    4
    The United States Court of Appeals for the Ninth Circuit affirmed the
    denial. Pacific Radiation Oncology, LLC v. Queen’s Medical Center, 
    810 F.3d 631
    (9th Cir. 2015).
    8
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER    ***
    claims and counterclaims.       He ordered the records discoverable
    as follows:
    Although the patient medical records contain protected
    health information (“PHI”), this does not preclude their
    discovery. As noted by Judge Kobayashi in the TRO Order,
    “[o]nce health information has been deidentified, it is no
    longer protected by HIPAA” or state law. TRO Order at 29.
    It reasonably follows that PHI is discoverable if de-
    identified. Accordingly, the 132 patient medical records
    shall be de-identified. Upon de-identification, the
    medical records will be discoverable and shall be produced.
    The Plaintiffs appealed the Magistrate Judge’s decision to the
    District Court.      After granting 19 affected patients’ motion to
    intervene, the District Court reserved ruling on the Plaintiffs’
    appeal and certified the instant questions to this court.
    III.    Discussion
    Article I, section 6 of the Hawaii Constitution is entitled
    “Right to Privacy,” and it provides, “The right of the people to
    privacy is recognized and shall not be infringed without the
    showing of a compelling state interest.          The legislature shall
    take affirmative steps to implement this right.”            In the context
    of patient medical records, this court has issued three
    decisions construing article I, section 6 on petitions for writ
    of mandamus:    Brende v. Hara, 113 Hawaii 424, 
    153 P.3d 1109
    (2007) (per curiam); Naipo v. Border, 125 Hawaii 31, 
    251 P.3d 594
    (2011) (per curiam); and Cohan v. Ayabe, 132 Hawaii 408, 
    322 P.3d 948
    (2014).
    9
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER    ***
    Each of the mandamus petitioners in these cases sought to
    compel the respondent judges to issue orders limiting and/or
    prohibiting the use of patient medical records.            The mandamus
    petitioners in Brende and Cohan were both plaintiffs in tort
    litigation in which their medical condition and treatment were
    at issue.    The petitioner in Naipo, on the other hand, was not a
    party to the litigation.       Rather, in Naipo, the parties to a
    dog-bite lawsuit sought discovery of a non-party’s patient
    medical records.     This distinction is key in the instant
    proceedings, which involve patient intervenors who are not
    parties to the lawsuit between Plaintiffs and QMC.            Each of
    these cases will be discussed in turn, below.
    Brende, Cohan, and Naipo all provide strong privacy
    protection over patient medical records. In Brende, this court
    held, “Petitioners’ health information is ‘highly personal and
    intimate’ information that is protected by the informational
    prong of article I, section 6.        The constitutional provision
    protects the disclosure outside of the underlying litigation of
    petitioners’ health information produced in discovery.”             113
    Hawaii at 
    430, 153 P.3d at 1115
    (footnote omitted).            This
    holding was reaffirmed in Cohan.          See 132 Hawaii at 
    410, 322 P.3d at 950
    (“[T]he privacy provision of the Hawaii
    Constitution, article I, section 6, protects [the petitioner’s]
    10
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER    ***
    health information against disclosure outside the underlying
    litigation.”)
    The holding in Brende and Cohan applies to situations in
    which a party to litigation seeks to limit and/or prohibit the
    disclosure, outside of discovery, of his or her own patient
    medical records.     While that is not the situation in the present
    case (where non-parties seek to prohibit the use and disclosure
    of their patient medical records), we turn to Brende and Cohan
    for their exploration of the constitutional history behind
    article I, section 6.
    Brende noted that the framers viewed the Hawaii
    constitutional right to privacy as follows:
    [T]he [article I, section 6] right of privacy encompasses
    the common law right of privacy or tort privacy. This is a
    recognition that the dissemination of private and personal
    matters, be it true, embarrassing or not, can cause mental
    pain and distress far greater than bodily injury. For
    example, the right can be used to protect an individual
    from invasion of [the individual’s] private affairs, public
    disclosure of embarrassing facts, and publicity placing the
    individual in a false light. In short, this right of
    privacy includes the right of an individual to tell the
    world to “mind your own business.”
    113 Hawaii at 
    430, 153 P.3d at 1115
    (quoting Stand. Comm. Rep.
    No. 69, in Proceedings of the Constitutional Convention of
    Hawaii of 1978 (“Proceedings”), Vol. 1, at 674).
    So inviolable is this right that the framers sought to
    shield individuals from “possible abuses in the use of highly
    personal and intimate information in the hands of government or
    private parties. . . .”       Comm. Whole Rep. No. 15, in
    11
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER   ***
    Proceedings, at 1024 (emphasis added).          In this way, article I,
    section 6 provides Hawaii’s people with powerful protection
    against any infringement of their right to privacy, by state and
    private actors.     In fact, we have previously noted that the
    framers “equated privacy in the informational sense” with the
    “common law right of privacy,” so that “[o]ne who gives
    publicity to a matter concerning the private life of another is
    subject to liability to the other for invasion of his [or her]
    privacy, if the matter publicized is of a kind that (a) would be
    regarded as highly offensive to a reasonable person, and (b) is
    not of legitimate concern to the public.”          State of Hawaii
    Organization of Police Officers (“SHOPO”) v. Soc’y of Prof’l
    Journalists, 83 Hawaii 378, 398, 
    927 P.2d 386
    , 406 (1996)
    (citing Stand. Comm. Rep. No. 69, Proceedings, at 674; and
    Restatement (Second) of Torts § 652D, 383 (1977)).            There is no
    requirement that the one invading another individual’s privacy
    be a state actor.     See, e.g., SHOPO, 83 Hawaii 378, 
    927 P.2d 386
    (analyzing whether a non-state actor’s, e.g., an organization of
    journalists, access to police officer disciplinary records would
    violate the officers’ constitutional privacy rights).
    Article I, section 6 generally provides greater privacy to
    Hawaii’s people than its federal analogs.          The Hawaii
    constitutional right to privacy is a “fundamental right for
    12
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER     ***
    purposes of constitutional analysis.”            Cohan, 132 Hawaii at 
    415, 322 P.3d at 955
    (quoting Comm. Whole Rep. No. 15, in
    Proceedings, at 1024).         We view article I, section 6 as
    “afford[ing] much greater privacy rights than the federal right
    to privacy. . . .”        Janra Enters., Inc. v. City & Cty. of
    Honolulu, 107 Hawaii 314, 320, 
    113 P.3d 190
    , 196 (2005)
    (citation omitted).
    Article 1, section 6 also provides more stringent
    protection5 over patient medical records than does HIPAA.6                  This
    conclusion was implicit in Cohan, where a provision in a
    Stipulated Qualified Protection Order that provided that the
    5
    45 C.F.R. § 160.202(6) provides
    More stringent means, in the context of a comparison of a
    provision of State law and a standard, requirement, or
    implementation specification adopted under subpart E of
    part 164 of this subchapter, a State law that meets one or
    more of the following criteria: . . . .
    With respect to any other matter, provides greater privacy
    protection for the individual who is the subject of the
    individually identifiable health information.
    That regulation also defines “state law” to include a state’s constitution
    and common law. 
    Id. 6 We
    therefore are not persuaded by QMC’s contention that “Hawaii’s
    constitutional right of privacy is coextensive with HIPAA.” In support of
    this argument, QMC points to HRS Chapter 323B, Hawaii’s Health Care Privacy
    Harmonization Act, specifically section 3(a) in that chapter, which states in
    relevant part that a covered entity or business associate’s use or disclosure
    of individually identifiable health information that complies with HIPAA
    “shall be deemed to comply with all state laws relating to the use,
    disclosure, or confidentiality of such information.” HRS § 323B-4(6) (2010 &
    Supp. 2012), however, provides, “Nothing in this chapter shall be construed
    to . . . [l]imit or otherwise affect any evidentiary privilege, limitation on
    discovery, or confidentiality protection provided by any state law, decision,
    or order in relation to individually identifiable health information sought,
    used, or produced in any judicial or administrative proceeding.” Therefore,
    the intervenors’ constitutional right to privacy in their confidential
    medical records is unaffected by Chapter 323B. In other words, honoring an
    individual’s right to privacy in his or her protected health information
    requires more than bare compliance with HIPAA.
    13
    ***     FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER   ***
    defendant hotel could use a tort plaintiff’s health information
    in its internal reviews was invalidated under article I, section
    6, yet we noted that “[a]n analysis under HIPAA arguably may
    lead to a different result.”        132 Hawaii at 419, 419 
    n.18, 322 P.3d at 959
    , 959 n.18.
    The right to privacy is absolute where, as here, the
    individuals seeking to protect patient medical records, in
    discovery and beyond, are not parties to the litigation, have
    not consented to the use of their patient medical records in
    relation to the present lawsuit, and no compelling state
    interest has been shown.        Naipo is a case “on all fours” with
    the instant case.       In Naipo, plaintiff Eshell Mitchell sued the
    Yuen family in state court for multiple leg injuries she
    sustained when the Yuens’ dog, Braddah, bit her.             125 Hawaii at
    
    33, 251 P.3d at 596
    .       As part of her negligence claim, Mitchell
    sought to establish that Braddah had previously bitten Jennifer
    Naipo.    See 
    id. Mitchell issued
    a subpoena duces tecum to
    Wahiawa General Hospital for production of Naipo’s medical
    records.    See 
    id. The respondent
    judge denied Naipo’s motion to
    quash the subpoena and ordered the hospital to turn over Naipo’s
    medical records for an in camera inspection.            125 Hawaii at 
    34, 251 P.3d at 597
    .
    14
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER   ***
    Naipo then petitioned this court for a writ of mandamus,
    arguing that her health information was protected by, inter
    alia, her right to privacy under article I, section 6 of the
    Hawaii constitution.        
    Id. We granted
    Naipo’s petition for
    mandamus relief and ultimately directed the respondent judge to
    quash the subpoena duces tecum.           125 Hawaii at 
    37, 251 P.3d at 600
    .       We unequivocally held, “Petitioner Jennifer Naipo is not a
    party to Eshell Mitchell’s lawsuit against the Yuens.                Her
    health information in her medical records at Wahiawa General
    Hospital is protected by her constitutional right to privacy.”7
    125 Hawaii at 
    35, 251 P.3d at 598
    .
    Naipo’s holding provides our answer to the first certified
    question, which is, “May a party who is in lawful possession of
    a patient’s confidential medical records use, or be compelled to
    produce, these records in litigation where the patient is not a
    party?”       We hold that, pursuant to article I, section 6 of the
    Hawaii Constitution, and under the facts of this case, the
    parties cannot use, or be compelled to produce, confidential
    patient medical records in litigation where the patient is not a
    party, where no compelling state interest has been shown.
    7
    Our decision also rested on the twin holding that Naipo’s confidential
    medical records “deserve[d] the protection of the physician-patient privilege
    of [Hawaii Rules of Evidence] Rule 504,” which Naipo had not waived. 125
    Hawaii at 35, 
    36, 251 P.3d at 598
    , 599. We therefore are not persuaded by
    QMC’s argument that Naipo “held that the medical records were protected from
    disclosure to the trial judge on physician patient privilege grounds rather
    than privacy.”
    15
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER    ***
    The second certified question is, “Is a de-identification
    process sufficient to protect the patient’s privacy interests
    where the party already allowed its agents access to the
    patient’s records and its agents inadvertently made part of the
    patient’s medical information public?”         We doubt, under the
    circumstances of this case where there has been an egregious
    breach of patient confidentiality by QMC both internally and
    publicly, that de-identification is possible.           However, the
    question of the sufficiency of de-identification where one party
    already allowed its agents access to the patient’s records and
    its agents inadvertently made part of the patient’s medical
    information public, is ultimately a matter of compliance with
    HIPAA, which is a federal question we need not answer.             We can
    address under Hawaii law, however, that part of the second
    certified question asking if de-identification could
    sufficiently protect the patients’ privacy rights.            We answer
    that part of the second certified question in the negative.
    In Cohan, we held, “To allow [a party’s medical]
    information to be used outside the litigation, regardless of
    whether it is de-identified or not, would reach beyond what the
    Hawaii Constitution permits in the absence of a showing of a
    compelling state interest.”       132 Hawaii at 
    419, 322 P.3d at 959
    .
    16
    ***   FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER     ***
    In Cohan, we noted that the de-identification process under
    HIPAA is “extremely complex and problematic,” and that, “[a]part
    from these technical considerations, there is the very
    complicated issue as to whether a patient has a legitimate basis
    for being concerned about what happens to their personal health
    information once it is de-identified.”         132 Hawaii at 417, 
    418, 322 P.3d at 957
    , 958 (footnote omitted).         We quoted the
    following observation from the Seventh Circuit Court of Appeals
    with approval: “Even if there were no possibility that a
    patient’s identity might be learned from a redacted medical
    record, there would still be an invasion of privacy.”            Cohan,
    132 Hawaii at 
    418, 322 P.3d at 958
    (citing Nw. Mem’l Hosp. v.
    Ashcroft, 
    362 F.3d 923
    , 929 (7th Cir. 2004)). Such an invasion
    could produce undesirable effects upon patient health care,
    including “social and psychological harm through embarrassment,
    economic harm through job discrimination and job loss, patient
    difficulty in obtaining health insurance, health care fraud, and
    patient reluctance to share sensitive information with their
    doctors or pharmacists.”      132 Hawaii at 
    418, 322 P.3d at 958
    (quoting Christopher R. Smith, Somebody’s Watching Me:
    Protecting Patient Privacy in Prescription Health Information,
    
    36 Vt. L
    . Rev, 931, 943 (2012)).
    17
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER    ***
    Further, we observed that “the risk of re-identification
    remains, as there is ‘no national, uniform standard governing
    the level of identifier-stripping necessary to guarantee that
    de-identified data cannot be re-identified.”           132 Hawaii at 418
    
    n.16, 322 P.3d at 958
    n.16 (quoting 
    Smith, supra, at 935
    ).               The
    risk of re-identification poses “subjective privacy concerns”
    for some patients, who object to the “dehumanization [in] having
    one’s most intimate information circulated by an indifferent and
    faceless infrastructure without any control over the process or
    content.”   
    Id. (quoting Will
    Thomas DeVries, Protecting Privacy
    in the Digital Age, 18 Berkeley Tech. L.J., 283, 298 (2003)).
    We believe the same concerns underlying the use of de-
    identified medical records beyond litigation for parties to a
    lawsuit exist for individuals who are not parties to litigation
    and who have therefore not put their medical condition and/or
    treatment at issue in the first instance. Just as article I,
    section 6 protects parties from the use and production of their
    de-identified information outside of litigation, we conclude
    that article I, section 6 protects individuals from the use and
    production of their de-identified information in litigation to
    which they are not parties.       Thus, the use and production of
    even sufficiently de-identified medical records, under the
    circumstances of this case, will not adequately protect the
    patients from an invasion of their privacy.
    18
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER   ***
    We acknowledge that Cohan also stated the following:
    Once health information has been de-identified, it is no
    longer protected by HIPAA. Further, because HIPAA allows
    “more stringent” state law to preempt federal law only when
    it relates to the privacy of “individually identifiable
    health information,” 45 C.F.R. § 160.203(b), this leads to
    the conclusion that state law also does not protect de-
    identified information. Nw. Mem’l 
    Hosp., 362 F.3d at 926
    .
    132 Hawaii at 
    417, 322 P.3d at 957
    (latter emphasis added).             We
    consider the last statement to be an accurate summary of the
    holding in Nw. Mem’l Hosp., which was, more specifically, that
    Illinois’ medical-records privilege, while providing “more
    stringent” state law protection of “individually identifiable
    health information,” was no barrier to the discovery of de-
    identified health information.        See also Zyprexa Prods. Liab.
    Litig., 
    254 F.R.D. 50
    , 52 (E.D.N.Y. 2008) (similarly concluding,
    “the States’ [physician-patient] privilege laws pose no obstacle
    to the discovery of [patient] medical records, provided those
    records are de-identified.”).
    By contrast, our express holding in Cohan was, “To allow [a
    party’s medical] information to be used outside the litigation,
    regardless of whether it is de-identified or not, would reach
    beyond what the Hawaii Constitution permits in the absence of a
    showing of a compelling state interest.”          132 Hawaii at 
    419, 322 P.3d at 959
    .    Extending Cohan to cases in which parties seek to
    use and produce the medical records of non-parties, we hold that
    to allow an individual’s medical information, even if de-
    19
    ***    FOR PUBLICATION IN WEST’S HAWAII REPORTS AND PACIFIC REPORTER   ***
    identified, to be used in litigation to which that individual is
    not a party, would reach beyond what the Hawaii Constitution
    permits in the absence of a showing of a compelling state
    interest.    In this case, QMC has made no such showing, and we do
    not believe that a compelling state interest exists in
    infringing upon the Hawaii state constitutional privacy rights
    of over 100 cancer patients in order to resolve what is
    essentially a contract dispute between competing cancer
    treatment providers.
    IV.    Conclusion
    We answer both certified questions in the negative.
    Article I, section 6 of the Hawaii Constitution protects the
    health information of patient intervenors to this case.
    Pursuant to that provision, the parties cannot use, or be
    compelled to produce, confidential patient medical records, even
    if sufficiently de-identified, in litigation where the patient
    is not a party, as no compelling state interest has been shown.
    /s/ Mark E. Recktenwald
    /s/ Paula A. Nakayama
    /s/ Sabrina S. McKenna
    /s/ Richard W. Pollack
    /s/ Michael D. Wilson
    20